FDA/Center for Drug Evaluation and Research (CDER) to Genentech, Inc. - Letter
This Other document was issued by the Food and Drug Administration (FDA)
For related information, Open Docket Folder
...Proposal to Withdraw Marketing Approval; Notice of Oppotunity for A Hearing
No documents available.
| || |
Comment Period Closed
Show More Details
Date Posted: Dec 16, 2010
FDA, Please hold a public hearing to allow patients, along with their medical oncologists, to assist the drug company in making their case regarding Avastin...
Help me understand the logic in putting the fox in charge of the hen house and expect an impartial hearing as requested by Genentech. You were wise in...
This document is contained in
Related RINs: None
* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.